RxDoctor Payments Data

Betsy Bailey, MD

Family Medicine · Flemingsburg, KYNPI 1962474510

Payments from drug & device makers

$1,806in general payments, 2019–2025

Across 109 payments — averaging $16.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$298
  • AstraZeneca$233
  • Lilly USA, LLC$197
  • Novartis$163
  • Pfizer$156
  • GSK$134
  • plus $625 from 16 others

What the payments were for

  • Food & beverage$1,806100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,806 in reported general payments places this provider in the 65th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$1,136
Medicare patients
29
Services billed
67

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol44$46,659
OzempicSemaglutide45$42,535
EliquisApixaban47$30,458
JanuviaSitagliptin Phosphate28$27,078
Breztri AerosphereBudesonide/Glycopyr/Formoterol36$26,340
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$15,960
TrulicityDulaglutide16$15,257
MounjaroTirzepatide12$12,382
Breo ElliptaFluticasone/Vilanterol20$11,775
MultaqDronedarone Hcl13$11,763
SymbicortBudesonide/Formoterol Fumarate24$11,519
TradjentaLinagliptin11$9,603
EntrestoSacubitril/Valsartan14$9,454
BrilintaTicagrelor15$9,201
DexilantDexlansoprazole16$5,842

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort, Brilinta$233$93,719119 claims
Novo NordiskOzempic$98$42,53545 claims
GSKTrelegy Ellipta, Breo Ellipta, Shingrix$134$32,43757 claims
PfizerEliquis$156$30,45847 claims
Lilly USA, LLCTrulicity, Mounjaro$197$27,64028 claims
MerckJanuvia$18$27,07828 claims
Boehringer IngelheimTradjenta$73$9,60311 claims
NovartisEntresto$163$9,45414 claims
Takeda Pharmaceuticals U.S.A., Inc.Dexilant$34$5,84216 claims
AbbVieSynthroid$298$1,79128 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Flemingsburg

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →